Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
2015 · New England Journal of Medicine · 9,325 citations
https://doi.org/10.1056/nejmoa1507643
N
Neal Ready
Duke University(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
305
Papers
32.5K
Citations
48
h-index
124
i10-index
Neal Ready is an academic researcher from Duke University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Cancer Immunotherapy and Biomarkers & Lung Cancer Research Studies. The author has an h-index of 48, co-authored 260 publications.
ORCID: 0000-0003-4414-9432Papers by this author
worksFive-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non–Small-Cell Lung Cancer
2021 · Journal of Clinical Oncology · 625 citations
https://doi.org/10.1200/jco.20.01605
Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy
2018 · European Journal of Cancer · 262 citations
https://doi.org/10.1016/j.ejca.2018.11.015
Perioperative outcomes of pulmonary resection after neoadjuvant pembrolizumab in patients with non–small cell lung cancer
2021 · Journal of Thoracic and Cardiovascular Surgery · 107 citations
https://doi.org/10.1016/j.jtcvs.2021.02.099
Role of induction chemotherapy in sinonasal malignancies: a systematic review
2018 · International Forum of Allergy & Rhinology · 44 citations
https://doi.org/10.1002/alr.22229
International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy
2023 · Journal of Thoracic Oncology · 37 citations
https://doi.org/10.1016/j.jtho.2023.07.017
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat